Annual Cash & Cash Equivalents
$224.95 M
+$153.29 M+213.91%
31 December 2023
Summary:
Tarsus Pharmaceuticals annual cash & cash equivalents is currently $224.95 million, with the most recent change of +$153.29 million (+213.91%) on 31 December 2023. During the last 3 years, it has risen by +$56.82 million (+33.79%). TARS annual cash & cash equivalents is now at all-time high.TARS Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$176.21 M
-$4.88 M-2.70%
30 September 2024
Summary:
Tarsus Pharmaceuticals quarterly cash and cash equivalents is currently $176.21 million, with the most recent change of -$4.88 million (-2.70%) on 30 September 2024. Over the past year, it has dropped by -$50.46 million (-22.26%). TARS quarterly cash and cash equivalents is now -28.18% below its all-time high of $245.36 million, reached on 30 June 2022.TARS Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARS Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +213.9% | -22.3% |
| 3 y3 years | +33.8% | -4.1% |
| 5 y5 years | +9451.9% | - |
TARS Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +213.9% | -28.2% | +167.0% |
| 5 y | 5 years | at high | +9451.9% | -28.2% | +231.6% |
| alltime | all time | at high | +9451.9% | -28.2% | +231.6% |
Tarsus Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $176.21 M(-2.7%) |
| June 2024 | - | $181.09 M(-6.5%) |
| Mar 2024 | - | $193.71 M(-13.9%) |
| Dec 2023 | $224.95 M(+213.9%) | $224.95 M(-0.8%) |
| Sept 2023 | - | $226.67 M(+112.3%) |
| June 2023 | - | $106.77 M(+61.8%) |
| Mar 2023 | - | $66.00 M(-7.9%) |
| Dec 2022 | $71.66 M | $71.66 M(-57.7%) |
| Sept 2022 | - | $169.49 M(-30.9%) |
| June 2022 | - | $245.36 M(+40.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $175.01 M(+2.1%) |
| Dec 2021 | $171.33 M(+1.9%) | $171.33 M(-6.8%) |
| Sept 2021 | - | $183.80 M(+4.0%) |
| June 2021 | - | $176.74 M(+13.2%) |
| Mar 2021 | - | $156.18 M(-7.1%) |
| Dec 2020 | $168.13 M(+190.1%) | $168.13 M(+94.8%) |
| Sept 2020 | - | $86.33 M(+62.5%) |
| June 2020 | - | $53.13 M(-8.3%) |
| Dec 2019 | $57.95 M(+2360.8%) | $57.95 M |
| Dec 2018 | $2.35 M | - |
FAQ
- What is Tarsus Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Tarsus Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Tarsus Pharmaceuticals?
- What is Tarsus Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Tarsus Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of TARS is $224.95 M
What is the all time high annual cash & cash equivalents for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high annual cash & cash equivalents is $224.95 M
What is Tarsus Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, TARS annual cash & cash equivalents has changed by +$153.29 M (+213.91%)
What is Tarsus Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TARS is $176.21 M
What is the all time high quarterly cash and cash equivalents for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high quarterly cash and cash equivalents is $245.36 M
What is Tarsus Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, TARS quarterly cash and cash equivalents has changed by -$50.46 M (-22.26%)